期刊论文详细信息
Biomarkers in Cancer
PET Metabolic Biomarkers for Cancer: Supplementary Issue: Biomarkers and their Essential Role in the Development of Personalised Therapies (A)
EtienneCroteau1 
关键词: positron emission tomography;    FDG;    metabolism;    perfusion;    oncology;    cardiotoxicity;    radiotherapy;   
DOI  :  10.4137/BIC.S27483
学科分类:医学(综合)
来源: Sage Journals
PDF
【 摘 要 】

The body's main fuel sources are fats, carbohydrates (glucose), proteins, and ketone bodies. It is well known that an important hallmark of cancer cells is the overconsumption of glucose. Positron emission tomography (PET) imaging using the glucose analog 18F-fluorodeoxyglucose (18F-FDG) has been a powerful cancer diagnostic tool for many decades. Apart from surgery, chemotherapy and radiotherapy represent the two main domains for cancer therapy, targeting tumor proliferation, cell division, and DNA replication–-all processes that require a large amount of energy. Currently, in vivo clinical imaging of metabolism is performed almost exclusively using PET radiotracers that assess oxygen consumption and mechanisms of energy substrate consumption. This paper reviews the utility of PET imaging biomarkers for the detection of cancer proliferation, vascularization, metabolism, treatment response, and follow-up after radiation therapy, chemotherapy, and chemotherapy-related side effects.

【 授权许可】

CC BY   

【 预 览 】
附件列表
Files Size Format View
RO201901211532373ZK.pdf 389KB PDF download
  文献评价指标  
  下载次数:31次 浏览次数:3次